跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,751 条关于
“amylin receptor agonist”
全部
16,751
临床试验
9,000
药物
1,923
机构
67
资讯
5,761
去年
AstraZeneca Presents Promising Early Data on Oral GLP-1 Agonist AZD5004 and Amylin Agonist AZD6234 for Obesity Treatment
去年
Structure Therapeutics Advances Oral Amylin Agonist ACCG-2671 for Obesity Treatment
去年
Novo Nordisk's Amycretin Shows Promising Weight Loss in Phase 1b/2a Trial
5个月前
Amylin Drug Development Surges with $19 Billion Investment as Nearly 40 Programs Target Obesity Treatment
去年
Novo Nordisk's Amycretin Shows Promising Weight Loss in Early Trials
去年
Structure Therapeutics Advances Oral Obesity Drug Programs with Completed Enrollment in Key Aleniglipron Trials
9个月前
Novo Nordisk's Amycretin Shows Promising Phase 2 Results in Type 2 Diabetes, Advances to Phase 3 Trials
去年
Metsera to Showcase Next-Generation Obesity Therapies at ADA 2025 with Clinical Data from Ultra-Long Acting GLP-1 Agonist
去年
Viking Therapeutics and Structure Therapeutics Seen as Key Partners in Weight Loss Market
上个月
Cambridge Scientists Solve GIPR Paradox: Distinct Brain Circuits Explain Why Both Activating and Blocking the Same Receptor Drives Weight Loss
第 1 页,共 577 页
上一页
下一页